场所
发表于 2025-3-23 13:03:31
Gabriela Postolache,Raul Oliveira,Octavian Postolacheular graphs (especially highlighting chemical bonds), and we further integrate chemical domain knowledge, using functional groups and chemical element knowledge graph, which is the information on physicochemical properties of atoms. From molecular graphs to functional groups, and to atoms, the molec
Generic-Drug
发表于 2025-3-23 15:39:56
Stephanie Githa Nadarajah,Benjamin Nicholas Overgaard,Peder Walz Pedersen,Camilla Gisela Hansen Schnetabolic inhibitor actinomycin D, followed by mRNA degradation assays in vitro. Finally, repression of . mRNA translation can be estimated by comparing the expression of mRNA and protein changes. We herein report the strategic methods used in a series of analyses to elucidate the possible involvemen
音的强弱
发表于 2025-3-23 20:02:59
http://reply.papertrans.cn/48/4706/470587/470587_13.png
nonsensical
发表于 2025-3-23 23:55:23
http://reply.papertrans.cn/48/4706/470587/470587_14.png
银版照相
发表于 2025-3-24 03:31:48
http://reply.papertrans.cn/48/4706/470587/470587_15.png
grenade
发表于 2025-3-24 09:29:09
http://reply.papertrans.cn/48/4706/470587/470587_16.png
古代
发表于 2025-3-24 11:24:51
http://reply.papertrans.cn/48/4706/470587/470587_17.png
Atrium
发表于 2025-3-24 17:22:05
Chulin Yang,Stephen Jia Wangexpression of the CCN3 gene in mesangial cells markedly down-regulates CCN2 activity and blocks ECM over-accumulation stimulated by TGF-β. Conversely, TGF-β treatment reduces endogenous CCN3 expression and increases CCN2 activity and matrix accumulation, indicating an important, novel yin/yang effec
Rheumatologist
发表于 2025-3-24 21:10:19
Fiammetta Marulli,Luca Vallifuocong CCN6’s mechanism of function. We found that CCN6 loss triggers the process of epithelial to mesenchymal transition (EMT), which convert epithelial cells into migratory mesenchymal cells and thus drive breast cancers with metastatic ability. We have also found that CCN6 downregulation enhances the
妈妈不开心
发表于 2025-3-25 02:07:13
Ben Challis,Angela Kang,Rachel Rimmer,Mark Hildredad. Recently, we have shown that KLF15 is a novel negative regulator of CTGF expression in the heart via its ability to counteract Smad signaling at the CTGF promoter. From a clinical standpoint, progress has been made in utilizing CTGF levels as a biomarker for fibrotic diseases. In this chapter, w